Approval was based on its clinical benefit in older patients with newly diagnosed high-risk/secondary AML in a pivotal phase III trial. Treatment for groups I-III was idarubicin 8 mg/m(2) per day days 1-3, cytarabine 2000 mg/m(2) once a day days 1-6, and etoposide 1600 mg/m(2) total dose treatment of patients with T-cell ALL and T-cell lymphoblastic lymphoma who have not responded to or
Diagram of the treatment phases of pediatric acute lymphocytic leukemia | Download Scientific Diagram
Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML) Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia Acute cerebellar syndrome can be caused by high doses of cytarabine, but it has not been described in patients with acute lymphoblastic leukemia (ALL) who received hyper-CVAD chemotherapy.
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Chemotherapy regimen for acute myeloid leukaemia and acute… | Download Table
Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML) Onset of hyperglycemia in children receiving induction chemotherapy for ALL is temporally linked to administration of pegaspargase We present two pediatric patients who developed ascending motoric paraplegia (AMP) following intrathecal chemotherapy
Treatment Schema for Standard-Risk Acute Lymphoblastic … | GrepMed
Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia Acute cerebellar syndrome can be caused by high doses of cytarabine, but it has not been described in patients with acute lymphoblastic leukemia (ALL) who received hyper-CVAD chemotherapy. Although rarely reported in children, pediatricians should especially be aware of this reaction when taking care of children treatment of patients with T-cell ALL and T-cell lymphoblastic lymphoma who have not responded to or
Acute lymphoblastic leukaemia - The Lancet
High-dose cytarabine improves EFS for subset of infants with acute lymphoblastic leukemia
Both patients suffered from progressive weakness of their lower extremities, neurogenic bladder dysfunction, autonomous neural Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML) Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of
Chemotherapy protocol a for HR ALL patients | Download Table
Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia | Semantic Scholar
It is frequently occurred in patients with acute myeloid leukemia and lymphoma Onset of hyperglycemia in children receiving induction chemotherapy for ALL is temporally linked to administration of pegaspargase Especially in a type of acute lymphoblastic leukemia (ALL) that is refractory and easy to relapse, the expression of ERG protein is abnormally Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression Leuk Res
Acute Lymphocytic Leukemia Nursing Care Management: Study Guide
JCM | Free Full-Text | Approach to the Adult Acute Lymphoblastic Leukemia Patient
Summary of Known Cases of Cytarabine Induced Cerebral Vasospasm and… | Download Table
Table 1 from The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment | Semantic Scholar
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia - The Journal of Pediatrics
Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of Although rarely reported in children, pediatricians should especially be aware of this reaction when taking care of children Here, we reported 2 cases of acral erythema that developed during cytarabin-etoposide and cytarabine-mitoxantrone combination treatment for acute myeloid leukemia
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Both patients suffered from progressive weakness of their lower extremities, neurogenic bladder dysfunction, autonomous neural Hyper-CVAD is one of the most frequently used regimens for routine treatment of adult acute lymphoblastic leukemia (ALL) in many countries [1] Although rarely reported in children, pediatricians should especially be aware of this reaction when taking care of children
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study - The Lancet Oncology
Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population
Daunorubicin/cytarabine liposome is approved in several countries worldwide for the treatment of adults with therapy-related acute myeloid leukaemia (tAML) and AML with myelodysplasia-related changes (MRC) Hyper-CVAD is one of the most frequently used regimens for routine treatment of adult acute lymphoblastic leukemia (ALL) in many countries [1] Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of
Practical aspects of the use of intrathecal chemotherapy